JP Morgan Chase
CRBU icon

JP Morgan Chase’s Caribou Biosciences CRBU Stock Holding History

JP Morgan Chase’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76K Buy
42,929
+36,840
+605% +$72.8K ﹤0.01% 6238
2026
Q1 		$10.5K Sell
6,089
-512
-8% -$879 ﹤0.01% 6730
2025
Q4 		$10.5K Buy
+6,601
New +$13.9K ﹤0.01% 6664
2025
Q3 		– Sell
-710
Closed -$895 – 7440
2025
Q2 		$895 Sell
710
-803,844
-100% -$791K ﹤0.01% 6636
2025
Q1 		$735K Sell
804,554
-1,691,368
-68% -$2.2M ﹤0.01% 4550
2024
Q4 		$3.97M Buy
2,495,922
+2,062,563
+476% +$4.15M ﹤0.01% 3571
2024
Q3 		$849K Sell
433,359
-30,668
-7% -$62.8K ﹤0.01% 4573
2024
Q2 		$761K Sell
464,027
-85,026
-15% -$272K ﹤0.01% 4441
2024
Q1 		$2.82M Sell
549,053
-27,931
-5% -$172K ﹤0.01% 3570
2023
Q4 		$3.31M Buy
576,984
+4,606
+0.8% +$22.8K ﹤0.01% 3441
2023
Q3 		$2.74M Sell
572,378
-19,804
-3% -$123K ﹤0.01% 3310
2023
Q2 		$2.52M Sell
592,182
-10,796
-2% -$48.5K ﹤0.01% 3363
2023
Q1 		$3.2M Buy
602,978
+2,881
+0.5% +$17.9K ﹤0.01% 3170
2022
Q4 		$3.77M Sell
600,097
-1,253
-0.2% -$11.1K ﹤0.01% 3059
2022
Q3 		$6.34M Buy
601,350
+91,782
+18% +$855K ﹤0.01% 2518
2022
Q2 		$2.77M Sell
509,568
-6,190
-1% -$47.3K ﹤0.01% 3290
2022
Q1 		$4.74M Buy
515,758
+497,692
+2,755% +$5.24M ﹤0.01% 3055
2021
Q4 		$273K Buy
18,066
+11,002
+156% +$214K ﹤0.01% 5174
2021
Q3 		$169K Buy
+7,064
New +$173K ﹤0.01% 5322

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase's CRBU Position: Q2 2026 in Review

JP Morgan Chase increased its Caribou Biosciences (CRBU) stake by 605% in Q2 2026, buying an estimated $72.8K and bringing the position to 42,929 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #6238.

JP Morgan Chase first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.34M in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • JP Morgan Chase held 42,929 shares of Caribou Biosciences worth $76K as of Q2 2026.
  • JP Morgan Chase bought 36,840 Caribou Biosciences shares in Q2 2026, an estimated $72.8K.
  • Caribou Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6238 holding.
  • JP Morgan Chase first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Caribou Biosciences position peaked at $6.34M in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.